Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets innovative products and has a broad portfolio that addresses challenging medical conditions and significant clinical needs across two major markets, neuro and vascular. Penumbra sells its products to hospitals primarily through its direct sales organization in the United States, most of Europe, Canada and Australia, and through distributors in select international markets. The Penumbra logo is a trademark of Penumbra, Inc.

NYSE: PEN 166.83 +3.20 +1.96%
Volume: 266,556
Pricing delayed 20 minutes June 14, 2019 04:03 PM

SEC Filings

Date Filing Type Filing Description Download
Date June 13, 2019 Filing Type Form 4 Filing Description Statement of Changes in Beneficial Ownership Download
Date June 10, 2019 Filing Type Form SC 13G/A Filing Description Amended Statement of Ownership Download

IR Contact


Penumbra, Inc. Headquarters One Penumbra Place
Alameda, CA 94502